Senior Level Appointments, Sale of Portfolio Company, and Event Schedules - Research Reports on PNC, American Capital, FITB, Prudential Financial and ACE

NEW YORK, October 8, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding PNC Financial Services Group Inc. (NYSE: PNC), American Capital, Ltd. (NASDAQ: ACAS), Fifth Third Bancorp (NASDAQ: FITB), Prudential Financial, Inc. (NYSE: PRU) and ACE Limited (NYSE: ACE). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7015-100free.

--
PNC Financial Services Group Inc. Research Reports
On October 2, 2014, PNC Financial Services Group, Inc. (PNC) reported the appointment of Marjorie Rodgers Cheshire to its board of directors, effective immediately. Cheshire is President and Chief Operating Officer of A&R Companies, the umbrella organization for A&R Development Corp. and A&R Management, Inc. In addition, the PNC's Board of Directors declared a quarterly cash dividend on the common stock of $0.48 per share, payable on November 5, 2014 to shareholders of record at the close of business on October 15, 2014. The Board also declared the cash dividends on the preferred stocks series: quarterly dividend of $0.45 per share on Series B; quarterly dividend of $113.83 per share on Series K; quarterly dividend of $1,531.25 per share on Series P; quarterly dividend of $1,343.75 per share on Series Q; and semi-annual dividend of $2,425.00 per share on Series R. The full research reports on PNC are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/PNC/report.pdf

--
American Capital, Ltd. Research Reports
On October 2, 2014, American Capital, Ltd. (American Capital) and its affiliated fund, American Capital Equity III, LP (ACE III), announced the sale of their portfolio company Avalon Laboratories Holding Corp. (Avalon) to Nordson Corporation for $180 million. The Company informed that over the life of its investment, American Capital realized a compounded annual rate of return of 19% on its equity investment, including dividends and fees. "We are extremely pleased with the results of our investment in Avalon, which is the first exit for ACE III," said Eugene Krichevsky, Partner, American Capital Equity Management. "Avalon generated strong financial performance during our hold period, with double digit annual revenue and EBITDA growth despite the global recession. Led by a talented management team dedicated to innovation, the Company has become the leading supplier of complex medical tubing products for the cardiology and pulmonology market segments." The full research reports on American Capital are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/ACAS/report.pdf

--
Fifth Third Bancorp Research Reports
On September 23, 2014, Fifth Third Bancorp (FITB) reported that it will release its Q3 2014 financial results on October 16, 2014 at 6:30 a.m. ET. The financial results release will be followed by a conference call at 9:00 a.m. ET to discuss the financial performance. On average, analysts polled by Bloomberg Businessweek expect the Company to report Q3 2014 EPS of $0.44 on revenue of $1.5 billion. Analyst estimates typically exclude one-time items. The full research reports on FITB are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/FITB/report.pdf

--
Prudential Financial, Inc. Research Reports
On October 3, 2014, Prudential Financial, Inc. (Prudential Financial) reported that it will host a conference for analysts and investors in New York City, on June 17, 2015, in which John Strangfeld, CEO and Chairman, and other members of the senior management team will discuss the Company's businesses and strategies. The full research reports on Prudential Financial are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/PRU/report.pdf

--
ACE Limited Research Reports
On October 2, 2014, ACE Limited's (ACE's) subsidiary Combined Insurance announced the appointment of Art Kandarian, a retired Colonel, U.S. Army, as Vice President Sales, in line with its commitment to support the needs of the nation's military veterans and spouses. In his new role, Kandarian will be responsible for executing on the Company's growth strategy and developing Combined Insurance's nationwide military sales markets, as well as leading the integration of those markets with the Company's military veteran recruiting initiatives. Most recently, Kandarian served as chief of staff for NATO Special Operations Component Command/Special Operations Joint Task Force after retiring from the U.S. Army in 2013. The full research reports on ACE are available to download free of charge at:

http://www.analystsreview.com/Oct-08-2014/ACE/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED